Stephen Goldman
Chief Science Officer, Kaycha Labs

Mr. Goldman joined PhytaTech in 2015 (the predecessor company to Kaycha Labs Colorado). His primary areas of focus are the Colorado Lab Operations, Research & Development, New Test Development, and Nationwide Standardization.

Prior to joining Kaycha Mr. Goldman served as an analytical chemist at the CLIA and CAP certified Forensic Laboratories, was a chemist for Novartis (Sandoz), Kemin Industries, Genentech, and served as a contract chemist. In those capacities, he was involved in research into biocatalyst production, new chemistry entities, nutraceutical development, antibody conjugate linkers, technical transfers, quality control, analytical method development, and method creation and validation.

Mr. Goldman is a member of the American Institute of Chemical Engineers, American Association of Pharmaceutical Scientists and the American Chemical Society, Cannabis Chemistry Subdivision.

Featured In: